QUCY
NASDAQMainz Biomed N.V.
Price$2.04+0.07 (+3.82%)
01:30 PM07:45 PM
News · 26 weeks41+178%
2025-12-142026-06-07
Mix4190d
- SEC Filings18(44%)
- M&A11(27%)
- Insider6(15%)
- Other5(12%)
- Leadership1(2%)
Latest news
25 items- PRQuantum Cyber Signs LOI to Acquire an Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility to Support Mass-Scale Autonomous Drone ProductionWEST PALM BEACH, Florida, June 08, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced that its wholly owned subsidiary Quantum Drones Corporation has signed a Letter of Intent ("LOI") to acquire the real property and manufacturing equipment located at Bridgeport, Connecticut, from Arcade Technology LLC, for an aggregate purchase price of $3,200,000. The proposed acquisition represents an important step in Quantum Cyber's planned strategic transition from a techn
- SECMainz Biomed N.V. filed SEC Form 8-K: Termination of a Material Definitive Agreement8-K - Quantum Cyber N.V. (0001874252) (Filer)
- SECSEC Form S-3 filed by Mainz Biomed N.V.S-3 - Quantum Cyber N.V. (0001874252) (Filer)
- PRDrones-as-a-Service Market Surges as AI, Automation, and Industrial Demand Drive Billion-Dollar GrowthMarket forecasts point to multi-billion-dollar expansion as businesses increasingly adopt outsourced drone operations to reduce costs and improve efficiencyNEW YORK, June 3, 2026 /CNW/ -- Market News Updates News Commentary - The concept of Drones as a Service (DaaS) is rapidly gaining momentum within the broader AI, automation, and industrial technology sectors. This trend is driven by businesses seeking cost-effective solutions for drone operations without the need to internally manage fleets. Instead of investing heavily in various aspects like hardware, software, pilots, compliance, and maintenance, companies are turning to subscription and on-demand service models to outsource their dro
- SECMainz Biomed N.V. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Quantum Cyber N.V. (0001874252) (Filer)
- PRQuantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance SheetWEST PALM BEACH, Florida, June 03, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today published its inaugural Corporate Investor Presentation. The full presentation is available at https://quantum-cyber.ai/investors/presentations. The 19-slide deck consolidates the Company's previously announced milestones, technology portfolio, and strategic positioning into a single investor-facing document. Key sections include: Battle-Validated Autonomy and the QC-Core Platform. Ukra
- PRQuantum Cyber Assumes Direct Manufacturing of Autonomous Drone; Expands BP United AgreementWEST PALM BEACH, Florida, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced an expansion of its existing relationship with BP United Inc. ("BP United"), the developer of autonomous unmanned vehicle systems that form the foundation of the Company's autonomous drone platform. Quantum Cyber Assumes Direct Manufacturing ControlThe Company and BP United have executed a First Amendment to the Intellectual Property License Agreement dated May 12, 2026 (the "A
- SECSEC Form DEF 14A filed by Mainz Biomed N.V.DEF 14A - Quantum Cyber N.V. (0001874252) (Filer)
- SECMainz Biomed N.V. filed SEC Form 8-K: Other Events8-K - Quantum Cyber N.V. (0001874252) (Filer)
- PRQuantum Cyber Announces Plans to Establish U.S.-Based Defense-Technology Manufacturing Complex to Support Drone and Autonomous Systems DeliveryWEST PALM BEACH, Florida, May 28, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company, today announced a strategic initiative to establish a U.S.-based defense-technology manufacturing complex intended to support the production and delivery of autonomous drone and defense systems to end customers across federal government, Homeland Security, local government, and commercial sectors. Illustrations shown are conceptual and provided for marketing and visualization purposes only. Certain depicted systems, capabilities, payloads, specifications, and operational use cases may be under development, subject to change, or not currently
- PRQuantum Cyber Files Provisional Patent Application for Coaxial Dual-Propellant Grain Solid Rocket Motor Designed to Extend Range and Loiter Time of Defense UAVsWEST PALM BEACH, Florida, May 27, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced the filing of a provisional patent application with the United States Patent and Trademark Office covering a Coaxial Dual-Propellant Grain Solid Rocket Motor (the "CDPG-SRM") engineered to extend the operational range and mission endurance of unmanned aerial vehicles across defense, border security, and autonomous warfare applications. A Structural Shift in U.S. Defense Procurem
- INSIDERDirector Ben-Tzvi Avraham was granted 137,141 units of Ordinary Shares, increasing direct ownership by 6,857% to 139,141 units (SEC Form 4)4 - Quantum Cyber N.V. (0001874252) (Issuer)
- SECMainz Biomed N.V. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Quantum Cyber N.V. (0001874252) (Filer)
- SECSEC Form PRE 14A filed by Mainz Biomed N.V.PRE 14A - Quantum Cyber N.V. (0001874252) (Filer)
- SECSEC Form 144 filed by Mainz Biomed N.V.144 - Quantum Cyber N.V. (0001874252) (Subject)
- INSIDERNew insider O'Rourke Peter claimed no ownership of stock in the company (SEC Form 3)3 - Quantum Cyber N.V. (0001874252) (Issuer)
- INSIDERDirector Natan David was granted 137,141 units of Ordinary Shares (SEC Form 4)4 - Quantum Cyber N.V. (0001874252) (Issuer)
- PRDrones-Led Disruption Accelerates as Commercial Adoption Surges Across Industrial MarketsNext-Generation Drone-as-a-Service Platforms Reshape Infrastructure, Energy, and Construction Operations with Rapid Revenue ExpansionMarket News Updates News CommentaryNEW YORK, May 21, 2026 /CNW/ -- The Drones-as-a-Service (DaaS) market for commercial and industrial applications is entering a strong growth phase as companies increasingly shift away from owning drone fleets and instead outsource aerial data collection, inspection, and monitoring to service providers. This model is gaining traction across construction, agriculture, energy, mining, logistics, and infrastructure inspection, where drones significantly reduce operating costs, improve safety, and deliver faster, higher-resolution
- PRQuantum Cyber Files Provisional Patent with USPTO for Integrated Swarm Defense for Autonomous Ground VehiclesWEST PALM BEACH, Florida, May 21, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO) for its Quantum Drone Autonomous System (QDAS). The application, assigned USPTO Application No. 64/069,586 and filed May 19, 2026, covers a novel multi-layer architecture combining quantum-sensor-fused GPS-denied navigation, sentinel drone rotation protocols, aerial LIDAR pathfinding, and an integrated 12-dron
- PRQuantum Cyber Files Provisional Patent for Quantum-Navigated Amphibious Autonomous Ground Vehicle PlatformWEST PALM BEACH, Florida, May 20, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO) for its SCOUT-AX6 GUARDIAN: a quantum-navigated, amphibious, remote-controlled autonomous ground vehicle designed for multi-domain defense operations across land and water in GPS-denied environments. The provisional application, docket number QDI-2026-QDAS-001, was filed in May 2026. The sole inventor is Jacob Gitman, with Quantum Drone Inc. named as assignee. The Company
- PRQuantum Cyber Files Non-Provisional Patent Application With the USPTO for EMP-Shielding 3D-Printable Composite Filament for Drone and Defense ElectronicsWEST PALM BEACH, Florida, May 19, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced it has filed a non-provisional utility patent application with the United States Patent and Trademark Office (USPTO) for an Electromagnetic Pulse Shielding Composite Filament for Fused Deposition Modeling and Method of Manufacture Thereof. EMP Hardening as a Structural CapabilityThe patent application describes a multi-component composite thermoplastic filament formulated for use in standard fused deposition mode
- PRQuantum Cyber Files Patent with USPTO for Autonomous Naval Mine Countermeasure System Addressing Iran's Mining of the Strait of Hormuz and Trump Administration Homeland Security PrioritiesWEST PALM BEACH, Florida, May 19, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a company assembling an AI-powered, quantum-accelerated System-of-Systems autonomous defense platform, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO) for an Autonomous Distributed Naval Mine Countermeasure System. The filing, numbered 64/066-872, establishes a priority date for the Company's proprietary technology for autonomous detection and neutralization of underwater naval mines using unmanned aerial vehicle-deployed sensor and neutralization platforms. The technology is directly relev
- SECSEC Form 144 filed by Mainz Biomed N.V.144 - Quantum Cyber N.V. (0001874252) (Subject)
- SECMainz Biomed N.V. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - Quantum Cyber N.V. (0001874252) (Filer)
- PRQuantum Cyber to Exhibit at Special Operations Forces Week 2026WEST PALM BEACH, Fla, May 18, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced that the Company will participate as an exhibitor at Special Operations Forces Week (SOF Week) 2026, taking place May 18-21, 2026, at the Tampa Convention Center in Tampa, Florida. SOF Week is the premier annual convention for the global Special Operations Forces community, co-hosted by U.S. Special Operations Command (USSOCOM) and the Global SOF Foundation. The event convenes senior military leaders, defense procure
QUCY FAQ
5 questionsWhere does QUCY stock trade?
Mainz Biomed N.V. (QUCY) is listed on NASDAQ.What sector and industry is QUCY in?
Mainz Biomed N.V. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Mainz Biomed N.V. go public?
Mainz Biomed N.V. (QUCY) completed its IPO in 2021.What companies are similar to QUCY?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare QUCY side-by-side with any of them on Quantisnow.How can I track QUCY on Quantisnow?
Quantisnow aggregates Mainz Biomed N.V.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow QUCY to receive live email and push alerts on every new disclosure.